Seroprevalence of 34 human papillomavirus types in the German general population

被引:132
|
作者
Michael, Kristina M. [1 ]
Waterboer, Tim [1 ]
Sehr, Peter [1 ]
Rother, Annette [1 ]
Reidel, Ulrich [1 ]
Boeing, Heiner [2 ]
Bravo, Ignacio G. [1 ]
Schlehofer, Joerg [1 ]
Gaertner, Barbara C. [3 ]
Pawlita, Michael [1 ]
机构
[1] German Canc Res Ctr, Infect & Canc Program, D-6900 Heidelberg, Germany
[2] German Inst Human Nutr DIFE Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany
[3] Saarland Univ Hosp Homburg, Inst Virol, Homburg, Germany
关键词
D O I
10.1371/journal.ppat.1000091
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The natural history of infections with many human papillomavirus (HPV) types is poorly understood. Here, we describe for the first time the age-and sex-dependent antibody prevalence for 29 cutaneous and five mucosal HPV types from 15 species within five phylogenetic genera (alpha, beta, gamma, mu, nu) in a general population. Sera from 1,797 German adults and children (758 males and 1,039 females) between 1 and 82 years (median 37 years) were analysed for antibodies to the major capsid protein L1 by Luminex-based multiplex serology. The first substantial HPV antibody reactions observed already in children and young adults are those to cutaneous types of the genera nu (HPV 41) and mu (HPV 1, 63). The antibody prevalence to mucosal high-risk types, most prominently HPV 16, was elevated after puberty in women but not in men and peaked between 25 and 34 years. Antibodies to beta and gamma papillomaviruses (PV) were rare in children and increased homogeneously with age, with prevalence peaks at 40 and 60 years in women and 50 and 70 years in men. Antibodies to cutaneous alpha PV showed a heterogeneous age distribution. In summary, these data suggest three major seroprevalence patterns for HPV of phylogenetically distinct genera: antibodies to mu and nu skin PV appear early in life, those to mucosal alpha PV in women after puberty, and antibodies to beta as well as to gamma skin PV accumulate later in life.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program
    Ucakar, Veronika
    Jelen, Mateja M.
    Faust, Helena
    Poljak, Mario
    Dillner, Joakim
    Klavs, Irena
    VACCINE, 2013, 31 (43) : 4935 - 4939
  • [22] Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia (vol 46, pg 1647, 2008)
    Newall, A. T.
    Brotherton, J. M. L.
    Quinn, H. E.
    McIntyre, P. B.
    Backhouse, J.
    Gilbert, L.
    Esser, M. T.
    Erick, J.
    Bryan, J.
    Formica, N.
    MacIntyre, C. R.
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (02) : 302 - 302
  • [23] Seroprevalence and risk factors for human papillomavirus in Taiwan
    Wang, I. J.
    Viscidi, R.
    Hwang, K. C.
    Lin, T. Y.
    Chen, C. J.
    Huang, L. M.
    Chen, H. H.
    Chen, C. J.
    JOURNAL OF TROPICAL PEDIATRICS, 2008, 54 (01) : 14 - 18
  • [24] Seroprevalence of human papillomavirus type 16 in children
    Dunne, EF
    Karem, KL
    Sternberg, MR
    Stone, KM
    Unger, ER
    Reeves, WC
    Markowitz, LE
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (11): : 1817 - 1819
  • [25] Seroprevalence of human papillomavirus in a cohort of university men
    Garg, R.
    Carter, J.
    Lee, S.
    Moraros, J.
    Feng, Q.
    Stern, M.
    Kiviat, N.
    Koutsky, L.
    Galloway, D.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S103 - S104
  • [26] The seroprevalence of nine human papillomavirus types included in the nonavalent vaccine in unvaccinated women living in Puerto Rico
    Cruz, Angeline
    Ramos-Cartagena, Jeslie M.
    Panicker, Gitika
    Unger, Elizabeth
    Ortiz, Ana P.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)
  • [27] Factors associated with the seroprevalence of 26 cutaneous and two genital human papillomavirus types in organ transplant patients
    Sampogna, F.
    Bavinck, J. N. Bouwes
    Pawlita, M.
    Abeni, D.
    Harwood, C. A.
    Proby, C. M.
    Feltkamp, M. C. W.
    Euvrard, S.
    Naldi, L.
    Neale, R. E.
    Nindl, I.
    Pfister, H.
    Quint, W. G. V.
    Waterboer, T.
    JOURNAL OF GENERAL VIROLOGY, 2012, 93 : 165 - 174
  • [28] Seroprevalence and Determinants of Eight High-Risk Human Papillomavirus Types in Homosexual Men, Heterosexual Men, and Women: A Population-Based Study in Amsterdam
    Heiligenberg, Marlies
    Michael, Kristina M.
    Kramer, Merlijn A.
    Pawlita, Michael
    Prins, Maria
    Coutinho, Roel A.
    Dukers-Muijrers, Nicole H. T. M.
    Waterboer, Tim
    SEXUALLY TRANSMITTED DISEASES, 2010, 37 (11) : 672 - 680
  • [29] Comparative seroepidemiology of genital human papillomavirus infections in the general population in Singapore
    Khoo, N. K. H.
    Tan, L.
    Lim, W. Y.
    Chen, M. I. C.
    Chow, V. T. K.
    PUBLIC HEALTH, 2017, 142 : 1 - 3
  • [30] Knowledge about human papillomavirus and the HPV vaccine – a survey of the general population
    Camille C Ragin
    Robert P Edwards
    Jade Jones
    Natalie E Thurman
    Kourtney L Hagan
    Erin A Jones
    Cierra M Moss
    Ar'Lena C Smith
    Aletha Akers
    Susanne M Gollin
    Dwight E Heron
    Cecile Andraos-Selim
    Cornelius Bondzi
    Linda Robertson
    Emanuela Taioli
    Infectious Agents and Cancer, 4 (Suppl 1)